12:03 PM EDT, 04/30/2025 (MT Newswires) -- BioNexus Gene Lab ( BGLC ) said Wednesday it has regained compliance with Nasdaq's minimum bid price requirement of $1 per share for continued listing.
Shares of the company were down 6.1% in recent trading.
Price: 2.76, Change: -0.18, Percent Change: -6.12